LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
25,401,782
Share change
-6,130,999
Total reported value
$163,398,713
Put/Call ratio
157%
Price per share
$6.43
Number of holders
78
Value change
-$70,703,731
Number of buys
39
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q1 2019

As of 31 Mar 2019, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,401,782 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, Broadfin Capital, LLC, Sectoral Asset Management Inc, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, VHCP Management III, LLC, D. E. Shaw & Co., Inc., and BAKER BROS. ADVISORS LP. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.